Tyra Biosciences, Inc. TYRA Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tyra Biosciences, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tyra Biosciences, Inc.'s operating lease liabilities (current)?
- Tyra Biosciences, Inc. (TYRA) reported operating lease liabilities (current) of $488K in Q1 2026.
- How has Tyra Biosciences, Inc.'s operating lease liabilities (current) changed year-over-year?
- Tyra Biosciences, Inc.'s operating lease liabilities (current) increased by 14.6% year-over-year, from $426K to $488K.
- What is the long-term trend for Tyra Biosciences, Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Tyra Biosciences, Inc.'s operating lease liabilities (current) has grown at a 27.2% compound annual growth rate (CAGR), from $142K to $472K.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.